WebJun 18, 2024 · Find out how the clinical trial research of UConn Health's Dr. Biree Andemariam is offering new hope for patients living with the painful inherited red blood cell disease with a promising oral, once-a-day experimental medication that may have a meaningful future impact on patient lives. WebJun 19, 2024 · image: UConn School of Medicine's Dr. Biree Andemariam presented her latest phase 2 clinical trial findings in Amsterdam at the European Hematology Association meeting in June 2024. view more ...
Author notes - American Society of Hematology
WebMar 29, 2024 · Biree Andemariam, MD. Director, New England Sickle Cell Institute Associate Professor of Medicine Division of Hematology/Oncology University of … WebJan 6, 2024 · “When individuals living with sickle cell disease go to emergency departments, they are living in extreme amounts of pain,” said Dr. Biree Andemariam, chief medical officer of the Sickle Cell... low saturation color palette
Imara Presents Clinical Data on IMR-687 in Sickle Cell
Webtheir internal medicine specialty, plaintiff filed the AOM of Biree Andemariam, M.D., who opined that "the skill, care[,] and knowledge exercised by defendants . . . fell outside … WebBiree Andemariam * 1, Willem Scheele 2, Victor Gordeuk 3, Jo Howard 4, Julie Kanter 5, Perla Eleftheriou 6, ShivanPancham 7, Robert Hagar 8, Lois Clarke 9, Gershwin Blyden 10, Kevin Johnson 2, Eleanor Lisbon 2, Rahul Ballal 2 1University of Connecticut Health, Farmington, CT, USA, 2Imara, Boston, MA, USA, WebDr. Wizdom Powell Selected for 2024 Science for Psychology Award, Dr. Biree Andemariam Presented with 2024 Chairman’s Award by Sickle Cell Disease Association How COVID-19 Threatens the Careers of Women in Medicine UConn Health Researchers Win $2.5M NIH MERIT Award Outstanding Women in Medicine and Science Honored jay briscoe celebration of life